The impact of SARS-Cov-2 on the Nervous system and Mental Health

Curr Neuropharmacol. 2021 Jun 29. doi: 10.2174/1570159X19666210629151303. Online ahead of print.ABSTRACTThe World Health Organization declared the pandemic situation caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mild-moderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impairments of mental health. The current review aims to provide the available evidence about the effects of SARS-CoV-2 infection on mental health. The present data suggest that SARS-CoV-2 produces a wide range of impairments and disorders of the brain. However, a limited number of studies investigated the neuroinvasive potential of SARS-CoV-2. Although the main features and outcomes of COVID-19 are linked to severe acute respiratory illness. The possible damages on the brain should be considered, too.PMID:34191699 | DOI:10.2174/1570159X19666210629151303
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Source Type: research